Merck
MRKSend this update
Merck layoffs: 54 workers · WARN in NJ · Dec 11, 2026
Latest WARN names 54 workers in NJ.
People who work here
Verify a work email, then post with no name. A poll you start shows in the thread list. It stays open for 3 days unless you pick 1 or 7, and you can close it sooner. A private reply goes to Messages.
Loading…
People in this kind of work also look at
Ask someone who worked here
Ask for a reference, or what the job is really like. The reply goes to a private inbox. Your name stays off this page.
Loading…
Email me about Merck
Sign up first. We email the address on that account when a new WARN filing or layoff report is linked to Merck.
Checking account…Mail about more than this one employer is Premium: saved WARN searches and a weekly digest. Turn off or switch the employer email from your account.
Where to file if this is your employer
Latest WARN notice: New Jersey, 54 workers, layoff date Dec 11, 2026.
New Jersey unemployment is listed at up to $830 a week for 26 weeks. A waiting week applies.
File in New JerseyBenefit amounts are published estimates. Confirm the current rule with the state.
69.0K
$146.97
▲ 0.02%
None(0.2%)
announced Mar 16, 2022
8
layoff date Dec 11, 2026 · NJ · 54 affected
Low
H-1B base pay
Oct 2025 – Jun 2026$125,414
Median base · 112 filings
Middle half of filings
- Statisticians23$117,000
- Biochemists and Biophysicists16$117,000
- Biostatisticians12$141,000
- Chemists9$117,000
Rahway, NJ (62) · North Wales, PA (22) · West Point, PA (13)
Base wage on public H-1B filings, filed as Merck Sharp & Dohme LLC. Stock and bonus are not included. U.S. Department of Labor, LCA disclosure
AI Layoff Impact Summary
AI-poweredMerck announced layoffs on Mar 16, 2022, affecting 170 employees (0.2% of workforce). WARN filings indicate 8 active notices. Low risk — company appears stable.
All Posts
Everything in one feed
Confirmed: 163 impacted at Montour
Just saw the official notification for the Montour site come through. It’s 163 heads total. For those of us who have been around long enough, this feels like a repeat of what we saw back in '22, but the pace seems faster this time around. Management sent out the usual email about 'optimizing our manufacturing network,' but it doesn't make it any easier for the folks who got the calendar invite today. If you’re one of the 163, please make sure you download your performance reviews and any personal documents before your access is cut, as they usually shut everything down pretty quickly once the exit process starts. Solidarity to everyone affected; reach out if you need help with leads or referrals.
Is the Montour exit just the beginning for the PA footprint?
I’ve been watching the WARN notices for the Montour site and it’s honestly disheartening to see the headcount drop like this. I know leadership always uses the 'strategic realignment' buzzword, but does anyone actually believe we are done here? The vibe in the office lately is incredibly tense, and it feels like every department is waiting for the other shoe to drop. I’ve heard whispers that management is looking to consolidate even more operations outside of PA, but it’s all hearsay so far. If you're currently at a PA site, are you guys seeing any signs of a wind-down, or is it business as usual for the moment? Just trying to get a read on whether I should be polishing my resume now or if I’m just being paranoid. Any insight from people who have been through previous Merck restructurings would be appreciated.
Severance packages for the recent PA cuts
Just checking in to see if any of my colleagues impacted by the May 16th layoffs in Montour are willing to share what the severance terms are looking like this time around. I know the company likes to keep these things under wraps, but knowing what to expect is the only thing keeping me sane right now. Are they offering the standard weeks-per-year-of-service, or did they tighten the belt on those benefits too? It’s gut-wrenching to see so many talented people get shown the door while the stock price is still holding up decent. If you were affected, please let us know if they are providing any career transition support or if it’s just the bare minimum cash payout. For those of us still hanging on, it really helps to understand the 'worst case' scenario so we can prepare our finances accordingly. Good luck to everyone currently in the job hunt, this market is brutal right now.
Anyone else hearing about more site closures after Montour?
I’ve been seeing the chatter about the 163 roles cut in Montour last week, and honestly, the mood in the office today is absolute rock bottom. It feels like we are playing a game of musical chairs where someone keeps pulling chairs out of the room every month. Leadership keeps talking about 'optimizing our portfolio' and 'strategic agility' in the town halls, but we all know that's just corporate speak for cost-cutting to pad the quarterly earnings. My manager is acting like everything is business as usual, but you can see the panic in his eyes whenever a meeting invite from HR pops up on his calendar. I’ve been with Merck for over six years and I’ve never felt this uneasy about my tenure. Does anyone have any insight into if this is isolated to the PA site or if the restructuring is going to hit the R&D hubs next? I’m already dusting off my resume tonight. I really don't want to get blindsided by a 15-minute Zoom call on a Friday afternoon.
Is anyone actually safe right now?
Every week it's a new location, a new team, a new 'strategic realignment.' I’ve been with Merck for over six years, and I’ve never felt this level of instability. We keep hearing the 'innovation' and 'streamlining' buzzwords from leadership, but it feels like the pipeline is just being gutted to make the margins look prettier for the next earnings call. It’s impossible to focus on actual R&D when you’re constantly checking the internal newsletters to see if your site is next on the chopping block. Is there anyone left in the building who hasn't been touched by this? I’m exhausted by the constant fear-mongering and the lack of transparency from management. Seriously considering polishing the resume this weekend because I’m tired of waiting for the ax to fall.
Confirmed: 163 impacted in Montour
Just saw the official WARN notice for the Montour site. 163 roles cut as of May 16th. If you are reading this and were part of the group, I am genuinely sorry. This keeps feeling like a slow-motion car crash across the industry, but seeing the specific numbers hit PA today makes it feel way too real. Does anyone have insight on whether this is the end of the current wave, or is there another shoe waiting to drop before the quarter closes? My inbox is quiet, but the anxiety in the department is palpable. Hoping everyone finds a landing spot quickly. If you're in the affected group, start filing for benefits immediately and don't wait for HR to hold your hand through the transition.
Merck - What's the deal with 'voluntary' separation packages?
Has anyone else been approached about 'voluntary separation' opportunities recently at Merck? It's being framed as a chance to 'explore new horizons' and 'prioritize personal goals,' but it feels like a thinly veiled way to reduce headcount without a formal layoff. They're offering what sounds like a decent package, but the timing is making me super nervous. My team isn't in a particularly high-risk area, but you never know. It feels like they're trying to get people to self-select out. Has anyone taken one of these packages? What was your experience like? Are they being offered broadly or targeted? I'm trying to figure out if this is a company-wide push or something specific to certain divisions. Worried about job security and wondering if this is a good time to start polishing the resume, just in case.
Merck: Heard whispers of restructuring, anyone have details?
Hey everyone, I'm seeing a lot of unusual activity lately, but nothing concrete. Been hearing a lot of talk about 'organizational realignments' and 'strategic adjustments' being thrown around in meetings. My manager's been cagey when I ask for specifics, just keeps saying 'focus on your current priorities.' It feels like something's brewing under the surface. Anyone else in R&D or Manufacturing getting similar vibes? Are there any departments that seem to be hiring up while others are freezing? Curious if anyone has heard any specific numbers or timelines, even if it's just rumors. Trying to gauge the potential impact on my role and the company overall. Wondering if this is a precursor to something bigger or just standard operational changes. Any insights would be appreciated.
Anyone else seeing their team/dept getting leaner unofficially?
So, I haven't heard anything concrete about layoffs, and there's no official announcement, but it feels like my department is slowly shrinking. We had a couple of people leave for other opportunities recently, and no one's been backfilled. Then, there's the talk about 'streamlining' and 'focusing on core competencies.' My direct manager is suddenly very cagey about future projects and headcount projections. It's making it hard to plan anything, and frankly, it's creating a lot of anxiety. Is this just me, or are others experiencing a quiet drawdown in their areas? Feels like a slow bleed rather than a sudden cut, which is almost worse sometimes. Just trying to gauge the temperature across the company.
Performance reviews feeling a bit more… pointed lately?
Hey everyone, been at Merck for a few years now and things feel different this cycle. My manager's been asking a lot more specific questions about project impact and efficiency, almost like they're building a case for something. It’s not just the usual performance talk, it feels like they're looking for justifications for *why* we're here. Anyone else getting this vibe? Lots of talk about 'optimizing resources' and 'strategic alignment' in town halls, which usually translates to headcount. Trying not to spiral, but the air feels a bit heavy. Hope it's just the usual end-of-year jitters, but the tone feels…different. Just looking to see if anyone else is picking up on this shift.
Feeling the heat with the new 'efficiency drives'
Is it just me or has the push for 'efficiency' and 'cost savings' ramped up significantly across Merck recently? I'm in [mention a vague department like R&D or Operations] and we're getting bombarded with requests to cut costs, streamline processes, and do 'more with less'. It's starting to feel like they're setting the stage for something. My manager is being cagey when asked direct questions about headcount or future plans. Has anyone else experienced this intensified focus on efficiency? Are there specific initiatives being rolled out that feel like they're paving the way for reductions? Just want to gauge if this is a company-wide push or if I'm in a particularly scrutinized area. It’s making me a bit anxious about job security, to be honest.
Any whispers about site consolidation or restructuring?
Hey everyone, been seeing some chatter on other platforms and wanted to see if anyone here has heard anything concrete about potential site closures or major departmental restructuring at Merck. It feels like there's a lot of 'optimizing' and 'synergizing' going on, which usually precedes something bigger. My department's been unusually quiet lately, and there's a weird vibe in some of the team meetings. Just trying to get a sense of what's really happening before panic sets in. Anyone have any intel, even rumors? Trying to stay ahead of the curve here. What are your thoughts on the current business climate and its potential impact?
Are performance reviews getting harsher, or am I just paranoid?
So, my annual review just wrapped up and honestly, it felt different this year. I've always gotten solid ratings, but this time around, even with hitting most of my goals, the feedback was much more critical. It felt like they were really digging for areas of improvement, almost to the point of nitpicking. It’s not just me; I've overheard similar sentiments from colleagues in different departments. It makes you wonder if the company is starting to tighten the belt and use performance metrics as a justification for potential future cuts. We haven't heard anything concrete about layoffs, but the tone in management meetings has shifted. Anyone else notice a change in how performance is being evaluated or discussed lately? Feels like the bar is being raised significantly, or maybe the expectation is that fewer people will be meeting it. Just trying to gauge if this is a wider trend or if I'm just being overly sensitive.
Anyone else feeling the pressure with these 'strategic realignments'?
Hey everyone, been at Merck for a few years now, and lately, I've been noticing a lot of buzzwords like 'strategic realignment' and 'portfolio optimization' being thrown around in town halls and internal comms. It's not just me, right? My team's been given new objectives that feel a bit... ambiguous. We're also seeing more cross-functional project teams forming and then dissolving pretty quickly. It's creating a weird sense of uncertainty. Morale has definitely taken a dip, and people are quietly talking about what it all means. No official layoffs have been announced, thankfully, but this constant shifting feels like it's paving the way for something. Just wanted to see if anyone else is experiencing similar vibes or has any insights into what these 'realignment' efforts might actually entail. Curious to hear your thoughts.
Thoughts on recent leadership changes and their impact?
Seeing a lot of shuffling in senior leadership positions across different therapeutic areas. New VPs, new heads of departments. While change can be good, it feels a bit chaotic right now. It's making it hard to get a clear direction on long-term projects. My team's been hesitant to make big decisions because we're not sure if the new leadership will have different priorities. Is anyone else feeling this uncertainty? Are these changes strategic, or are they a sign of underlying issues within the company? Just trying to understand the bigger picture and how it might affect us on the ground. My direct manager is as in the dark as we are, which isn't exactly confidence-inspiring.
Is anyone else seeing more 'efficiency drives' popping up?
Lately, it feels like every other meeting has someone talking about 'optimizing processes' or 'streamlining workflows.' It's the usual corporate speak, but the frequency is definitely up. I'm in [mention a general department like 'Clinical Ops' or 'Manufacturing'] and we're being asked to cut down on [mention a vague resource like 'consumables' or 'travel budget'] without any real explanation of how this won't impact our ability to deliver. It feels like a precursor to something bigger, or maybe just a way to justify budget cuts down the line. Has anyone else experienced this shift in messaging? Wondering if it's company-wide or just specific to certain divisions. Trying not to panic, but it's hard to ignore the vibe.
Anyone else getting the 'do more with less' message lately?
Just wanted to put this out there – lately, the messaging from leadership, even in smaller team meetings, has been heavy on 'driving efficiency' and 'optimizing resources.' It's the typical corporate speak, but the frequency and emphasis feel different. It's almost like they're laying the groundwork for something without saying it directly. I've seen some roles being 'evaluated' for consolidation, and there's definitely a hiring freeze in place for non-critical positions. It's making me nervous, especially with no clear communication about what this all means long-term. Anyone else interpreting this as a precursor to layoffs, or is it just standard business cycle stuff that I'm reading too much into? The lack of transparency is what's really gnawing at me. Feels like we're all just waiting for the other shoe to drop.
Morale seems low across R&D - anyone else feeling this?
Hey all, I'm in R&D at Merck and lately, the vibe has been... off. People seem a lot more stressed than usual, and there's a general air of uncertainty. I know there haven't been any official announcements, but the whispers about restructuring and efficiency drives are everywhere. Project timelines have definitely been a topic of conversation, and it feels like some initiatives are being re-evaluated or slowed down. Honestly, it's starting to get to me. I've been here a while and usually, things feel more stable. Seeing colleagues anxious and hearing hushed conversations about potential changes makes it hard to stay focused. Is anyone else in a similar boat, or am I just overthinking things? Curious to hear if others are noticing this too, especially in different departments. Maybe it's just a cyclical thing, but it feels more pronounced this time around.
Quiet on the 'merger integration' front - what gives?
I'm getting a bit antsy here at Merck. We had all that talk about the recent acquisition and how it was going to streamline operations and create synergies. For a while, there was a lot of activity and restructuring announcements. But lately, it's gone eerily quiet. The integration seems to have hit a wall, or at least, communication about its progress has. We're not hearing about new roles being created or any significant changes to existing structures, but we also aren't hearing anything about where we stand long-term. It feels like a lot of uncertainty is being managed poorly. Is anyone else in a department heavily impacted by this integration feeling the same way? Are there any internal updates being shared that I'm missing? The lack of clear communication is starting to fuel some serious anxiety. Feels like we're just waiting for the other shoe to drop.
Anyone else noticing a shift in project timelines? Things feel... paused.
Hey everyone, just wanted to see if anyone else at Merck is feeling this weird vibe lately. I know there haven't been official announcements about layoffs, but the general atmosphere feels off. My team's been hearing a lot of 'project prioritization' and 'strategic realignment' talk, but it's translating into a bunch of projects getting put on indefinite hold or timelines being pushed back indefinitely. It's not just my department; I've heard similar whispers from colleagues in other areas too. Hiring has also slowed to a crawl, which isn't exactly a confidence booster. It's making it hard to plan and feel secure about where things are heading. Is this just a normal cycle, or is anyone else sensing something more significant might be brewing behind the scenes? Curious to hear your thoughts.
Unusual silence on headcount and hiring freezes
It's been months now where the usual trickle of new hires has completely stopped. No internal job postings for roles that used to be common, and external requisitions seem to be in limbo indefinitely. Managers are being really cagey when asked about hiring plans or filling vacant positions. The official line is usually something vague about 'strategic workforce planning' or 'optimizing our talent acquisition process.' But the reality on the ground is that teams are stretched thin, and the lack of new blood is noticeable. I've heard whispers about a de facto hiring freeze, but nothing concrete from HR or leadership. It's creating a lot of anxiety because you wonder if this is a temporary pause or a sign of bigger things to come. Anyone else in a similar boat? Feels like the company is holding its breath, and we're all just waiting for the other shoe to drop, or for some clarity on the strategy behind this hiring vacuum.
Project Portfolio Review - Seeing a lot of projects shelved?
Lately, it feels like almost every other week a project I'm involved with or hear about is getting put on the back burner, or worse, completely shelved. It's not just one or two, it's across different departments and therapeutic areas. They're talking about 'strategic realignment' and 'prioritization,' but it feels like more than just a normal portfolio review. Budgets are being scrutinized intensely, and approvals for even minor expansions or new initiatives are taking forever, if they come at all. Anyone else seeing this pattern? It's making it hard to plan long-term, and honestly, the morale impact is starting to show. Feels like we're being asked to do more with less, and the 'why' isn't always clear. Just feels like a general tightening, but without any official word on what's actually happening. Curious to hear if others are experiencing this widespread project slowdown.
Subtle Shifts in Team Structures?
Has anyone else noticed subtle but persistent changes in how teams are being organized or re-aligned? It's not a big, flashy announcement, but more like gradual reshuffling, some roles quietly disappearing, and others being absorbed. Coupled with the obvious hiring freeze, it gives the impression of a slow, internal restructuring. Maybe it's just efficiency measures, but the lack of clear communication about it is unsettling. Feels like we're all trying to connect the dots without a roadmap. Wondering if this is a widespread observation or if I'm just hyper-aware in my specific group.
Rethinking Project Scope - Anyone Else Feeling the Squeeze?
Lately, it feels like every new project proposal, and even existing ones, are under extreme scrutiny. Not just from a scientific perspective, but financially. We're being asked to justify every single line item, and the budgets that *are* approved seem significantly leaner than they were even a year ago. It's not just me, right? I've overheard colleagues talking about having to scale back ambitious plans or even postpone initiatives because the funding just isn't there. It makes you wonder if this is a temporary belt-tightening or something more strategic. Anyone else experiencing this across different departments? How are you adapting?
Project funding feels unusually constrained lately
I'm working on a project that's usually well-funded, but recently the budget requests are getting scrutinized way more than usual. We're being asked to justify every dollar, and even then, approvals are slow and sometimes come back reduced. It's not just my team; I've heard similar stories from friends in other divisions. It makes you wonder if there's a broader belt-tightening happening behind the scenes. Are there major strategic shifts or financial pressures we aren't being told about? It's definitely impacting morale and productivity when you feel like you're constantly fighting for resources. Anyone else experiencing this level of budget pressure, and what are your theories?
Am I the only one noticing the lack of new hires?
Been at Merck for a few years now, and it feels like the hiring spigot has been turned off. Usually, this time of year, we'd be seeing new faces or at least job postings for open roles. But lately? Crickets. I've talked to a few colleagues in different departments, and they're seeing the same thing. It's not just a few roles, it's a widespread slowdown. I know companies do hiring pauses sometimes, but this feels different. It's not just about filling immediate needs; it feels like a strategic shift. Anyone else in R&D, commercial, or any other area seeing this? Is this a prelude to something bigger, or is there a new talent acquisition strategy I'm missing?
The silence on headcount is deafening
The 'efficiency drives' and 'strategic realignments' are getting old. What's really concerning is the complete lack of transparency around hiring. It's not just that it's slow; it feels like it's completely frozen. We had roles open for months that are now just... gone. Not posted, not filled, just disappeared from the internal site. Managers are super cagey when you ask about new hires or backfills. It used to be you'd hear *something* through the grapevine, even rumors. Now, it's just crickets. This feels different than past cycles. It’s not just a seasonal lull; it’s a strategic pause, but one they’re not communicating. Makes you wonder what the long-term plan is and if our departments are even part of it.
Project pivots and budget scrutiny - what's the endgame?
Been here a few years and the vibe has definitely shifted. It used to be that once a project got approved, you had a pretty solid runway. Now, it feels like every quarter is a new battle for funding. We're seeing a lot of project scope changes mid-stream, almost like they're trying to trim fat before it even gets going. Some initiatives that seemed like big priorities even six months ago are now being sidelined or scaled back significantly. It's not just the R&D side either; operations and support functions are feeling it too. Has anyone else noticed a marked increase in budget review meetings and a general air of 'prove your worth' for every dollar spent? Feels like we're prepping for something, but nobody's saying what.
Quiet restructuring or just efficiency drives?
I've been hearing a lot of talk lately about 'efficiency' and 'streamlining operations.' On the surface, it sounds like standard corporate speak, but combined with the hiring freeze and the way projects are being re-evaluated, it's starting to feel like more than just buzzwords. Some teams seem to be getting leaner, with existing members absorbing more work. Are these just normal operational adjustments, or is anyone else picking up on signals that might indicate a more significant internal shift? It's hard to get a clear picture, and the lack of direct communication is only fueling the speculation. Just trying to gauge if this is a company-wide trend or if I'm perhaps overthinking things based on my team's specific situation. Any insights from other parts of Merck would be helpful.
Hiring has completely ground to a halt
I've been tracking open positions at Merck for a while now, and it's like the faucet just turned off. A few months ago, there were tons of roles opening up, especially in [mention a department like R&D or IT]. Now? Very little movement. Even roles that were posted and then paused seem to be permanently off the radar. My own team was supposed to hire two new people this quarter, and that's been indefinitely postponed. It's not just a slow-down; it feels like a full stop. I'm starting to think it's more than just a seasonal lull. Is this a company-wide hiring freeze? What does this mean for future growth and opportunities within Merck? Feels like a bad omen, even if there's no official word on layoffs. Just feels like the company is holding its breath.